Monte Rosa Therapeutics
GLUE
#6712
Rank
C$1.05 B
Marketcap
C$12.39
Share price
-3.03%
Change (1 day)
-38.21%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2026 (TTM): C-$2.37

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is C-$2.45. In 2025 the company made an earnings per share (EPS) of C-$1.11 an increase over its 2024 EPS that were of C-$1.48.

EPS history for Monte Rosa Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$2.37114.23%
2025C-$1.11-25.22%
2024C-$1.48-60.93%
2023C-$3.7915.28%
2022C-$3.28